Exelixis Inc. Common Stock vs MiniMed Group Inc. Common Stock — how do they compare? Exelixis Inc. Common Stock trades at $60.43 (market cap $14.62B), while MiniMed Group Inc. Common Stock trades at $19.5 (market cap $5.57B). The key difference: Exelixis Inc. Common Stock is far larger — about 2.6× MiniMed Group Inc. Common Stock's market cap, and Exelixis Inc. Common Stock is trading nearer its 52-week high, MiniMed Group Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Exelixis Inc. Common Stock for 0 Days and MiniMed Group Inc. Common Stock for 0 Days on average.
| EXEL | MMED | |
|---|---|---|
Market Cap | $14.62B | $5.57B |
Volume | 2,684,957 | 23,336,073 |
Sector | Health | Health |
52-Week High | $59.13 | $23.84 |
52-Week Low | $34.54 | $10.80 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $13.95B | $5.37B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Exelixis develops and commercializes medicines for cancer. Its research focuses on targeted therapies for oncology.
Read more on EXEL →MiniMed develops, manufactures, and markets diabetes-management technologies. Its products include insulin-delivery systems, continuous glucose monitors, smart insulin pens, and related software.
Read more on MMED →